The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity

Ítems similars

• The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
  per: Niamh McGarry, et al.
  Publicat: (2015-01-01)
• Proteases and antiproteases in chronic neutrophilic lung disease – relevance to drug discovery
  per: Greene, Catherine M, et al.
  Publicat: (2009)
• Secretory Leucoprotease Inhibitor Impairs Toll-Like Receptor 2- and 4-Mediated Responses in Monocytic Cells
  per: Greene, Catherine M., et al.
  Publicat: (2004)
• The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
  per: Twigg, Matthew S., et al.
  Publicat: (2015)
• Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
  per: Taggart, Clifford C., et al.
  Publicat: (2005)